PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)
Public ClinicalTrials.gov record NCT00043368. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Continuation Study Of PF-3512676 (CPG 7909) Injection In Patients With Metastatic Or Recurrent Malignancies Who Have Stable Disease Or Who Have Responded To Pf-3512676 Injection Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This protocol allows patients who completed Coley oncology studies using PF-3512676 (CPG 7909) Injection to continue receiving the treatment until disease progression.
Study identification
- NCT ID
- NCT00043368
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 31 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2002 (Type not available)
- Primary completion
- Jun 2007 (Actual)
- Completion
- Jun 2007 (Actual)
- Last update posted
- Mar 12, 2009
2002 – 2007
United States locations
- U.S. sites
- 31
- U.S. states
- 11
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Berkely | California | 94704 | — |
| Pfizer Investigational Site | Gilroy | California | 95020 | — |
| Pfizer Investigational Site | Hollister | California | 95023 | — |
| Pfizer Investigational Site | Los Angeles | California | 90057 | — |
| Pfizer Investigational Site | Los Angeles | California | 91342 | — |
| Pfizer Investigational Site | Palm Springs | California | 92262 | — |
| Pfizer Investigational Site | Stanford | California | 94305 | — |
| Pfizer Investigational Site | New Haven | Connecticut | 06504 | — |
| Pfizer Investigational Site | Bonita Springs | Florida | 34135 | — |
| Pfizer Investigational Site | Bradenton | Florida | 34209 | — |
| Pfizer Investigational Site | Cape Coral | Florida | 33990 | — |
| Pfizer Investigational Site | Fort Myers | Florida | 33901 | — |
| Pfizer Investigational Site | Fort Myers | Florida | — | — |
| Pfizer Investigational Site | Naples | Florida | 34102 | — |
| Pfizer Investigational Site | Plantation | Florida | 33324 | — |
| Pfizer Investigational Site | Port Charlotte | Florida | 33980 | — |
| Pfizer Investigational Site | Sarasota | Florida | 34232 | — |
| Pfizer Investigational Site | Venice | Florida | 34285 | — |
| Pfizer Investigational Site | Venice | Florida | 34292 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60611-3124 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60611 | — |
| Pfizer Investigational Site | Vincennes | Indiana | 47591 | — |
| Pfizer Investigational Site | Ann Arbor | Michigan | 48109 | — |
| Pfizer Investigational Site | Olive Branch | Mississippi | 38654 | — |
| Pfizer Investigational Site | Oxford | Mississippi | 38655 | — |
| Pfizer Investigational Site | Livingston | New Jersey | 07039 | — |
| Pfizer Investigational Site | Asheville | North Carolina | 28801 | — |
| Pfizer Investigational Site | Portland | Oregon | 97213 | — |
| Pfizer Investigational Site | Collierville | Tennessee | 38107 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38017 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00043368, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 12, 2009 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00043368 live on ClinicalTrials.gov.